ETRA Stock Chart & Stats
13.25
--
―
--
Day’s Range― - ―
52-Week Range13.25 - 15.50
Previous CloseN/A
VolumeN/A
Average Volume (3M)5.12M
Market Cap
$809.58M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding61,100,290
10 Day Avg. Volume5,124,319
30 Day Avg. Volume5,124,319
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Electra Therapeutics Inc. News
ETRA FAQ
What was Electra Therapeutics Inc.’s price range in the past 12 months?
Electra Therapeutics Inc. lowest stock price was 13.25 and its highest was 15.50 in the past 12 months.
What is Electra Therapeutics Inc.’s market cap?
Electra Therapeutics Inc.’s market cap is $809.58M.
When is Electra Therapeutics Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Electra Therapeutics Inc.’s earnings last quarter?
Currently, no data Available
Is Electra Therapeutics Inc. overvalued?
According to Wall Street analysts Electra Therapeutics Inc.’s price is currently Undervalued.
Does Electra Therapeutics Inc. pay dividends?
Electra Therapeutics Inc. does not currently pay dividends.
What is Electra Therapeutics Inc.’s EPS estimate?
Electra Therapeutics Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Electra Therapeutics Inc. have?
Electra Therapeutics Inc. has 61,100,290 shares outstanding.
What happened to Electra Therapeutics Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Electra Therapeutics Inc.?
Currently, no hedge funds are holding shares in ETRA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Electra Therapeutics Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
Company Description
Electra Therapeutics Inc.
Electra Therapeutics, Inc. is a clinical stage biotechnology company. It is engaged in therapies against novel targets for diseases in immunology and cancer. The company was founded by Adam Rosenthal on October 11, 2018 and is headquartered in South San Francisco, CA.